November 14, 2013
Rapamycin, an anti-rejection drug for organ transplant patients, has now been shown to increases survival in and delayed symptoms of Leigh’s syndrome. The drug appears to cause a metabolic switch that bypasses the mitochondrial deficiency.
Panorama of our nearest galactic neighbor unveils hundreds of millions of stars 4 days ago
Office of Civil Rights concludes UW investigation with resolution agreement, no finding of liability or wrongdoing 5 days ago
A smart ring with a tiny camera lets users point and click to control home devices 2 weeks ago